Medicines For Europe Highlights Industry Agenda
Annual Meeting To Address EU Pharma Legislation, IP Reforms, Supply Chain And AMR
Executive Summary
Ahead of its annual meeting in Malta in mid-June, European off-patent industry association Medicines for Europe has set out the hot topics for generics and biosimilars stakeholders that delegates will be looking to discuss.
You may also be interested in...
European Proposals Outline Compulsory Licensing And SPC Changes
A fresh EU patent package launched by the European Commission proposes an EU-wide compulsory licensing mechanism in times of crisis, as well as a unitary SPC for medicines, centralized SPC grants and a clearer framework for issuing standard essential patents.
Industry Speaks Out On Global Antibiotics Shortages
Responding to shortages of antibiotics seen around the world, the IGBA has insisted that the generics industry is working to address spikes in demand and has set out a series of recommendations to mitigate the situation. Meanwhile, US association the AAM has countered suggestions that supply issues are due to a “broken generic drug market.”
Shortlist Revealed Ahead Of October Awards
Ahead of the Global Generics & Biosimilars Awards, which are this year being held on Wednesday 25 October at the Hotel Porta Fira in Barcelona, we reveal our final shortlist of entrants across all 14 categories.